Big Pharma Defuses Drug Pricing Landmines On Capitol Hill

 
• By Jessica Merrill

Industry's top leaders weren't exactly eager to testify on Capitol Hill. Now they might be wondering why they waited so long. Seven pharma leaders avoided missteps during a Senate Finance Committee hearing on drug pricing Feb. 26.

Pharma CEOs testify at Senate Finance Committee hearing 2-26-19
• Source: Win McNamee/Getty Images (Win McNamee/Getty Images)

More from Pricing Debate

More from Market Access